SG Americas Securities
MRVI icon

SG Americas Securities’s Maravai LifeSciences MRVI Stock Holding History

SG Americas Securities’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,996
Closed -$71K – 3569
2026
Q1 		$71K Sell
24,996
-402,287
-94% -$1.36M ﹤0.01% 2988
2025
Q4 		$1.39M Sell
427,283
-72,952
-15% -$246K ﹤0.01% 1758
2025
Q3 		$1.44M Sell
500,235
-226,507
-31% -$578K ﹤0.01% 1166
2025
Q2 		$1.75M Buy
726,742
+30,835
+4% +$64.8K 0.01% 839
2025
Q1 		$1.54M Buy
695,907
+662,861
+2,006% +$2.62M 0.01% 899
2024
Q4 		$180K Buy
33,046
+2,239
+7% +$14.4K ﹤0.01% 2252
2024
Q3 		$256K Buy
+30,807
New +$266K ﹤0.01% 2283
2024
Q2 		– Sell
-52,753
Closed -$457K – 3136
2024
Q1 		$457K Sell
52,753
-41,003
-44% -$277K ﹤0.01% 1475
2023
Q4 		$614K Buy
+93,756
New +$606K 0.01% 1340
2022
Q4 		– Sell
-8,395
Closed -$214K – 3260
2022
Q3 		$214K Sell
8,395
-76,827
-90% -$1.93M ﹤0.01% 2274
2022
Q2 		$2.42M Buy
85,222
+82,360
+2,878% +$2.61M 0.03% 634
2022
Q1 		$101K Buy
2,862
+185
+7% +$6.2K ﹤0.01% 2769
2021
Q4 		$112K Buy
+2,677
New +$108K ﹤0.01% 3022
2021
Q3 		– Sell
-2,637
Closed -$110K – 3872
2021
Q2 		$110K Buy
+2,637
New +$102K ﹤0.01% 2618
2021
Q1 		– Sell
-24,000
Closed -$673K – 3454
2020
Q4 		$673K Buy
+24,000
New +$668K ﹤0.01% 1762

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

SG Americas Securities's MRVI Position: Q2 2026 in Review

SG Americas Securities sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 24,996 shares — an estimated $71K sold.

SG Americas Securities first reported a position in MRVI in Q4 2020 and held it in 15 quarters. The position peaked at $2.42M in Q2 2022. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • SG Americas Securities reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 24,996 Maravai LifeSciences shares in Q2 2026, an estimated $71K.
  • SG Americas Securities first reported a position in Maravai LifeSciences in Q4 2020 and held it in 15 quarters.
  • SG Americas Securities's Maravai LifeSciences position peaked at $2.42M in Q2 2022.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.